Phase I Trial (FAB1/2 Fragments of R24 Melanoma

Houghton, Alan N.

Abstract

Funding Agency

• Agency: National Institute of Health (NIH)
• Institute: Division of Cancer Treatment (NCI)
• Type: Research and Development Contracts (N01)
• Project #: N01CM047665-002006
• Application #: 3612090
• Project Start: 1985-09-30
• Budget Start: 1991-07-16
• Budget End: 1987-06-30
• Fiscal Year: 1991

Institution

• Name: Memorial Hospital for Cancer & Allied Di
• City: New York
• State: NY
• Country: United States
• Zip Code: 10021

Publications

Bajorin, D F; Chapman, P B; Wong, G et al. (1990) Phase I evaluation of a combination of monoclonal antibody R24 and interleukin 2 in patients with metastatic melanoma. Cancer Res 50:7490-5